RarePipelinepeopleInnovationCollaborationCareersFinance Advance treatment Skip to main contentSkip to navigationSkip to search
Hansa Biopharma
HNSA (, %) SEK
Hansa Biopharma
Researcher examining bacteria

Media resources

Welcome to Hansa Biopharma's media resource center. This page houses information and media materials developed for media professionals only. They are not intended for use by healthcare professionals, patients, or the general public. Journalists are invited to use this material to illustrate their reporting.
corporate.communications@hansabiopharma.com

Antibodies